靜脈輸液袋的全球市場按輸液類型、營養素規模、份額和增長分析 - 2022-2028 年行業預測

Global Intravenous IV Fluid Bags Market Size, Share, Growth Analysis, By Fluid Type(Total Parenteral Nutrients, Peripheral Parenteral Nutrition), By Nutrients(Carbohydrates, Vitamins) - Industry Forecast 2022-2028

出版日期: 2022年11月16日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

到 2028 年，全球靜脈輸液袋市場規模將從 2021 年的 17 億美元達到 34.9 億美元，在預測期內 (2022-2028) 以 10.86% 的複合年增長率增長。預測。人口老齡化有助於市場的全球增長。

本報告研究和分析全球靜脈袋市場，提供市場動態和前景、細分市場分析、公司概況等。

內容

執行摘要

調查方法

母市場分析

主要市場考慮因素

技術分析
價格分析
供應鏈分析
價值鏈分析
市場生態系統
知識產權分析
貿易分析
啟動分析
原材料分析
創新矩陣
管道產品分析
宏觀經濟指標
主要投資分析
關鍵成功因素
競爭程度

市場動態和前景

市場動態
司機
機會
約束因素
任務
監管情況
波特的五力分析
對未來混亂的特殊考慮

全球靜脈輸液袋市場：按輸液類型分類

市場概覽
全腸外營養
外周腸外營養

全球靜脈輸液袋市場：按營養成分分類

市場概覽
碳水化合物
維生素
礦物質
單劑量氨基酸
腸外脂肪乳劑
其他

全球各地區靜脈輸液袋市場規模

市場概覽
北美
美國
加拿大
歐洲
德國
西班牙
法國
英國
其他歐洲
亞太地區
中國
印度
日本
韓國
亞太其他地區
拉丁美洲
巴西
其他拉丁美洲
中東和非洲
海灣合作委員會國家
南非
其他中東和非洲地區

競爭格局

前 5 家公司的比較
主要公司的市場定位（2021 年）
主要市場公司採用的策略
關鍵成功策略
最近的市場活動
主要公司的市場份額（2021 年）

主要公司簡介

Fresenius Kabi AG (Germany)
Pfizer, Inc. (US)
Otsuka Pharmaceutical Co., Ltd. (Japan)
Baxter (US)
B. Braun Melsungen AG (Germany)
Vifor Pharma Management Ltd. (Switzerland)
JW Life Science (South Korea)
Amanta Healthcare (India)
ICU Medical Inc. (US)
Grifols, S.A. (Spain)

簡介目錄

Product Code: SQSG35A2033

Global Intravenous IV Fluid Bags Market was valued at USD 1.7 billion in 2021 and it is expected to reach at USD 3.49 billion by 2028, at a CAGR of 10.86% over the forecast period (2022-2028).

Medical fluid bags are constructed of an internal pouch and an exterior plastic coating and available in a variety of sizes. Up until the projected expiration date printed on the bags, the fluids are safeguarded by the compartmentalization of these bags into an inner pouch and an exterior coating. These bags are widely used in medical facilities with a multipurpose approach to maintain adequate sterilised conditions for the blood samples that help in ensuring infection-free premises, limiting the spread of disease, and preventing any loss of blood samples or pharmaceuticals.These bags are also used in fluid replacement therapy, which ensures accurate body fluid collection, blood transfusions, correction of electrolyte imbalances, and maintenance of the patient's appropriate nutritional intake via an oral or enteral route of delivery.

End-users are using disposable IV fluid bags more frequently in an effort to reduce healthcare expenditures and avoid hospital acquired infections and cross-contamination. Also, they are gaining popularity at blood bank facilities in order to meet the demand for emergency blood infusions as well as to treat other blood-borne disorders. Furthermore, PVC-free bags composed of non-latex components are being manufactured by IV fluid bag producers to deliver IV fluids precisely and safely.

Moreover, bespoke combinations that are cold, frozen, or both can be kept in these fluid bags. As a result, the market is anticipated to expand in the next years as a result of both an increase in innovations and a growing preference for IV fluid bags over traditional IV bags.

Top-down and bottom-up approaches were used to estimate and validate the size of Asia Pacific Intravenous IV Fluid Bags Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The global Intravenous IV fluid bags market is segmented based on fluid type, nutrient, and region. Based on fluid type, the market is segmented into total parenteral nutrition and peripheral parenteral nutrition. On the basis of nutrient, the market can be bifurcated into carbohydrates, vitamins and minerals, single dose amino acids, parenteral liquid emulsion segments. The regional insights of the market are into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa.

Driver

The older population is contributing to the global growth of the intravenous fluid bags market. Many disorders associated with ageing necessitate the adoption of efficient drug administration methods. Medications given intravenously are preferred to those given orally since the former results in more rapid and precise results. The preference for intravenous fluid administration is anticipated to increase with more consumer knowledge, and this will promote market expansion over the course of the anticipated period.

Restraint

The IV bag market may suffer as a result of the risk of infection and vein collapse brought on by the needle remaining in place for an extended period of time. Inadequate monitoring of intravenous therapy can potentially result in nutrient imbalances in the patient's body.

The availability of substitutes, such as plastic bottles, glass bottles, and infusion pumps to regulate the flow of solution into veins, may be a hindrance to the IV fluid bags industry. An electrolyte solution of this size, which is generally produced in IV bags of the customary 1 litre size, should not be introduced to children.

Market Trends

The rising prevalence of different chronic conditions, including diabetes, cancer, cardiovascular diseases, kidney infections, and liver disorders, is one of the key reasons driving the growth of the medical fluid bags market globally. A further factor driving industrial expansion is the rise in gastrointestinal illnesses, particularly in the senior population. Patients' health may be negatively impacted by the usage of PVC-based medical fluid bags, and the environment may suffer from incorrect disposal. The growth of the market can be slowed by these problems. The globalisation of hospitals and the healthcare sector, on the other hand, has led to a large rise in the usage of intravenous fluid bags.